Congress Asset Management CO Spectrum Pharmaceuticals Inc Transaction History

Congress Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$3.38 - $5.14 $366,013 - $556,600	-108,288 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$2.11 - $3.38 $7,638 - $12,235	3,620 Added 3.46%	108,288 $366,000
Q4 2019 Feb 10, 2020	SELL	$3.5 - $10.35 $101,727 - $300,822	-29,065 Reduced 21.73%	104,668 $381,000
Q3 2019 Nov 01, 2019	SELL	$7.03 - $9.7 $94,658 - $130,610	-13,465 Reduced 9.15%	133,733 $1.11 Million
Q1 2019 May 08, 2019	SELL	$9.08 - $11.84 $23,199 - $30,251	-2,555 Reduced 1.71%	147,198 $1.57 Million
Q4 2018 Jan 25, 2019	BUY	$6.39 - $16.99 $40,097 - $106,612	6,275 Added 4.37%	149,753 $1.31 Million
Q3 2018 Oct 26, 2018	BUY	$16.52 - $24.82 $939,657 - $1.41 Million	56,880 Added 65.68%	143,478 $2.41 Million
Q2 2018 Jul 25, 2018	BUY	$14.31 - $21.75 $669,278 - $1.02 Million	46,770 Added 117.43%	86,598 $1.82 Million
Q1 2018 May 11, 2018	BUY	$16.09 - $23.07 $640,832 - $918,831	39,828 New	39,828 $641,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.